| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.24 | 8e-07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |